Risks Associated With Lentiviral Vector Exposures and Prevention Strategies
Ryan Schlimgen(Mass General Brigham), Jatin M. Vyas(Broad Institute), Dawn P. Wooley(Boston University), Thomas Winters(Boston University), Otto O. Yang(University of California, Los Angeles), David V. Diamond(Boston University), Jeffrey A. Gelfand(Harvard University), Gustavo Mostoslavsky(Boston University), T Hudson(Boston University), Karen B. Byers(Boston University), Lindsey R. Baden(Brigham and Women's Hospital), John Howard(Boston University), David C. Christiani(Harvard University), Elizabeth Gilman Duane(Boston University), Maureen Thompson(Boston University), Gary R. Fujimoto(Boston University)
Cited by 161
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969